Related Experiment Videos

The DMSA scan in paediatric urinary tract infection

M R Ditchfield1, H R Nadel

  • 1British Columbia's Children's Hospital, Vancouver, Canada.

Australasian Radiology
|December 2, 1998
PubMed

Insights

Dimercaptosuccinic acid (DMSA) scans frequently reveal kidney defects in children with urinary tract infections, even without vesico-ureteric reflux. These defects indicate potential scarring and highlight DMSA scan importance in pediatric UTI management.

Area of Science:

  • Pediatric Nephrology
  • Diagnostic Imaging
  • Infectious Diseases

Background:

  • Urinary tract infections (UTIs) are common in children and can lead to renal scarring.
  • Dimercaptosuccinic acid (DMSA) scintigraphy is a key imaging modality for detecting pyelonephritis and renal scars.
  • Vesico-ureteric reflux (VUR) has been traditionally associated with renal damage in UTIs.

Purpose of the Study:

  • To review the utilization of DMSA scans in pediatric UTIs.
  • To determine the frequency of cortical defects identified by DMSA scans.
  • To assess the association between VUR and cortical defects in children with UTIs.

Main Methods:

  • Retrospective study of 129 children with UTIs undergoing DMSA scans over a 2-year period.
  • Analysis of DMSA scan results for the presence of renal cortical defects.
  • Correlation of DMSA findings with micturating cysto-urethrogram (MCU) results in a subset of patients.

Main Results:

  • Overall, 31% of kidneys evaluated with DMSA scans showed cortical defects.
  • In children who also had an MCU, 30% had VUR, and 40% of those with VUR had cortical defects.
  • Importantly, 31% of kidneys without VUR also exhibited cortical defects on DMSA scans.

Conclusions:

  • Renal cortical defects are common in pediatric UTIs, as detected by DMSA scans.
  • These defects can occur frequently even in the absence of VUR.
  • DMSA scans are crucial for identifying kidneys at risk of scarring, and MCU alone is insufficient for screening.

Related Concept Videos